Causal relationship between type I diabetes mellitus and atrial fibrillation: A Mendelian randomization study
- PMID: 40129655
- PMCID: PMC11932688
- DOI: 10.1016/j.ijcha.2025.101643
Causal relationship between type I diabetes mellitus and atrial fibrillation: A Mendelian randomization study
Abstract
Background: Patients with type 1 diabetes mellitus have been at heightened risk for developing atrial fibrillation. We aimed to investigate whether this association is causal using Mendelian randomization.
Methods: Using publicly available genome-wide association studies data, we selected single nucleotide polymorphisms significantly associated with type 1 diabetes mellitus as instrumental variables. We employed inverse variance-weighted, weighted median, MR-Egger regression, simple mode, and weighted mode methods within a two-sample Mendelian randomization framework to assess the causal relationship between type 1 diabetes mellitus and atrial fibrillation. We evaluated the pleiotropy and heterogeneity levels of the included genetic instruments using MR-PRESSO, MR-Egger intercept test, Cochran's Q test, funnel plots, and leave-one-out plots.
Results: Causal impact of type 1 diabetes mellitus on atrial fibrillation: Inverse variance weighted (odds ratio [OR] = 0.996, 95 % confidence interval [CI]: 0.985-1.007, P = 0.498). MR-Egger (OR = 1.000, 95 % CI: 0.985-1.016, P = 0.963). Weighted median (OR = 0.985, 95 % CI: 0.973-0.998, P = 0.022). Simple mode (OR = 1.007, 95 % CI: 0.974-1.040, P = 0.698). Weighted mode (OR = 0.995, 95 % CI: 0.984-1.005, P = 0.298). MR-Egger intercept test (P = 0.437). There was no evidence of pleiotropy among the genetic instrumental variables included in the analysis.
Conclusions: In Mendelian randomization analysis, we did not find evidence of a causal relationship between genetically determined type 1 diabetes mellitus in European ancestry populations and atrial fibrillation.
Keywords: Atrial fibrillation; Genome-wide association; Mendelian randomization; Type 1 diabetes mellitus.
© 2025 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures





References
-
- Joglar J.A., Chung M.K., Armbruster A.L., et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1–e156. doi: 10.1161/cir.0000000000001193. - DOI - PMC - PubMed
-
- Dahlqvist S., Rosengren A., Gudbjörnsdottir S., et al. Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study. Lancet Diabetes Endocrinol. 2017;5(10):799–807. doi: 10.1016/s2213-8587(17)30262-0. - DOI - PubMed
LinkOut - more resources
Full Text Sources